Search research articles
Contact Us
Filters
Showing results (81-90 of 175) with videos related to
Page
of 18
Sort By:
Human Genomics
|
August 31, 2017
Falling giants and the rise of gene editing: ethics, private interests and the public good
Benjamin Capps, Ruth Chadwick, Yann Joly, et al.
Clinical Epigenetics
|
April 24, 2015
Risk of re-identification of epigenetic methylation data: a more nuanced response is needed
Yann Joly, Stephanie Om Dyke, Warren A Cheung, et al.
Facets (Ottawa)
|
December 20, 2016
Evolving data access policy: The Canadian context
Stephanie O M Dyke, Katie M Saulnier, Tomi Pastinen, et al.
The American Journal of Bioethics : AJOB
|
January 7, 2012
Are we asking the right ethics questions on drug shortages? Suggestions for a global and anticipatory ethics framework
Vural Ozdemir, Yann Joly, Edward S Dove, et al.
Stem Cell Reviews and Reports
|
March 29, 2014
Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements
Maroussia Lévesque, Jihyun Rosel Kim, Rosario Isasi, et al.
Environmental Epigenetics
|
November 26, 2020
Communicating science: epigenetics in the spotlight
Stephanie O M Dyke, Catherine A Ennis, Yann Joly, et al.
Human Genomics
|
May 31, 2019
Statement on bioinformatics and capturing the benefits of genome sequencing for society
Benjamin Capps, Ruth Chadwick, Yann Joly, et al.
The CRISPR Journal
|
March 24, 2022
Auditing the Editor: A Review of Key Translational Issues in Epigenetic Editing
Katherine Huerne, Nicole Palmour, Angela Ruohao Wu, et al.
BMC Medical Ethics
|
December 26, 2014
An implementation framework for the feedback of individual research results and incidental findings in research
Adrian Thorogood, Yann Joly, Bartha Maria Knoppers, et al.
British Medical Bulletin
|
March 24, 2017
Ethical issues of CRISPR technology and gene editing through the lens of solidarity
John J Mulvihill, Benjamin Capps, Yann Joly, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 175) with videos related to
Sort By:
Page
of 18
Human Genomics
|
August 31, 2017
Falling giants and the rise of gene editing: ethics, private interests and the public good
Benjamin Capps, Ruth Chadwick, Yann Joly, et al.
Clinical Epigenetics
|
April 24, 2015
Risk of re-identification of epigenetic methylation data: a more nuanced response is needed
Yann Joly, Stephanie Om Dyke, Warren A Cheung, et al.
Facets (Ottawa)
|
December 20, 2016
Evolving data access policy: The Canadian context
Stephanie O M Dyke, Katie M Saulnier, Tomi Pastinen, et al.
The American Journal of Bioethics : AJOB
|
January 7, 2012
Are we asking the right ethics questions on drug shortages? Suggestions for a global and anticipatory ethics framework
Vural Ozdemir, Yann Joly, Edward S Dove, et al.
Stem Cell Reviews and Reports
|
March 29, 2014
Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements
Maroussia Lévesque, Jihyun Rosel Kim, Rosario Isasi, et al.
Environmental Epigenetics
|
November 26, 2020
Communicating science: epigenetics in the spotlight
Stephanie O M Dyke, Catherine A Ennis, Yann Joly, et al.
Human Genomics
|
May 31, 2019
Statement on bioinformatics and capturing the benefits of genome sequencing for society
Benjamin Capps, Ruth Chadwick, Yann Joly, et al.
The CRISPR Journal
|
March 24, 2022
Auditing the Editor: A Review of Key Translational Issues in Epigenetic Editing
Katherine Huerne, Nicole Palmour, Angela Ruohao Wu, et al.
BMC Medical Ethics
|
December 26, 2014
An implementation framework for the feedback of individual research results and incidental findings in research
Adrian Thorogood, Yann Joly, Bartha Maria Knoppers, et al.
British Medical Bulletin
|
March 24, 2017
Ethical issues of CRISPR technology and gene editing through the lens of solidarity
John J Mulvihill, Benjamin Capps, Yann Joly, et al.
Page
of 18